Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-21-056641
Filing Date
2021-04-28
Accepted
2021-04-28 17:13:29
Documents
6
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2112455d2_10ka.htm 10-K/A 204819
2 EXHIBIT 31.1 tm2112455d2_ex31-1.htm EX-31.1 8553
3 EXHIBIT 31.2 tm2112455d2_ex31-2.htm EX-31.2 8666
4 EXHIBIT 32.1 tm2112455d2_ex32-1.htm EX-32.1 4306
5 EXHIBIT 32.1 tm2112455d2_ex32-2.htm EX-32.1 4262
6 GRAPHIC tm2112455d2_10kaimg01.jpg GRAPHIC 2399
  Complete submission text file 0001104659-21-056641.txt   235209
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

EIN.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36856 | Film No.: 21865488
SIC: 2834 Pharmaceutical Preparations